The Cancer Letter
By The Cancer Letter
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by The Cancer Letter
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 5
Reviews: 0
Episodes: 91
Description
The Cancer Letter, an independent weekly news publication, has been the leading source for information on the issues that shape oncology since 1973.
With a dedicated audience of oncology’s leaders, The Cancer Letter stays on top of breaking news and advances in oncology, providing authoritative, award-winning coverage of the development of cancer therapies, drug regulation, legislation, cancer research funding, health care finance, and public health.
This weekly podcast features interviews, discussions, and more to dig deep into the issues that shape oncology.
| Episode | Date |
|---|---|
|
Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes
|
Jun 03, 2026 |
|
The Directors: NCORP PIs discuss the growing complexity of regulatory oversight in clinical cancer research
|
May 29, 2026 |
|
As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon
|
May 27, 2026 |
|
The Cancer History Project debuts first de novo book; meanwhile, FDA snafus continue
|
May 20, 2026 |
|
Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)
|
May 13, 2026 |
|
Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time
|
May 06, 2026 |
|
On the joys of reporting on art as a tool for cancer education
|
Apr 30, 2026 |
|
The Directors: NCORP PIs discuss the growing complexity of regulatory oversight in clinical cancer research
|
Apr 30, 2026 |
|
The Directors: Byrd and Chapman speak about avoiding catastrophism and using bridge funding to keep labs open
|
Apr 24, 2026 |
|
No need for a speculum? A new era of HPV screening
|
Apr 22, 2026 |
|
NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
|
Apr 15, 2026 |
|
HHS Secretary Kennedy’s diet advice is heavy on meat and light on scientific consensus
|
Apr 08, 2026 |
|
With early-onset colorectal cancer on the rise, CRC screening is no longer just your parents’ problem
|
Apr 01, 2026 |
|
The Directors: Wistar’s Altieri and ChristianaCare’s Petrelli say partnership of their institutions will go on as the guard changes
|
Mar 27, 2026 |
|
At a jam-packed NCAB meeting, cancer vaccines and site visits take center stage
|
Mar 25, 2026 |
|
CBER Director Vinay Prasad dared to “say no to drugs”
|
Mar 18, 2026 |
|
One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
|
Mar 11, 2026 |
|
Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
|
Mar 04, 2026 |
|
Joni Nelson tells us how her background led her to pursue research that meets the needs of the community
|
Feb 27, 2026 |
|
The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient
|
Feb 27, 2026 |
|
Fires, F-bombs, and facemasks—Study results show impact of LA fires on firefighter cancer risk
|
Feb 25, 2026 |
|
Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology
|
Feb 20, 2026 |
|
Lowy fields questions about peer review at inaugural meeting of the new NCAB ad hoc working group
|
Feb 18, 2026 |
|
One year of The Cancer Letter Podcast: “When you publish a story, there is, you hope, conversation.”
|
Feb 11, 2026 |
|
Black History Month: Otis Brawley shares how lessons learned in West Side Detroit shape his stance on cancer prevention
|
Feb 06, 2026 |
|
The soul of oncology: Centering patient stories amid funding saga
|
Feb 04, 2026 |
|
The Directors: Gary Schwartz and Ramon Parsons on the best of times (for science), the worst of times (for funding)
|
Jan 30, 2026 |
|
“There is no safe harbor:” FY26 funding bill collapses after ICE shooting of Alex Pretti
|
Jan 28, 2026 |
|
With five-year cancer survival at an all-time high, does this mean people are living longer?
|
Jan 21, 2026 |
|
Could mRNA vaccines hold the key to building an affordable universal cancer vaccine?
|
Jan 14, 2026 |
|
Nancy Goodman: “Sen. Sanders says he cares about kids with cancer. I'm just asking him to show us.”
|
Jan 07, 2026 |
|
Otis Brawley looks back on a year of great science and greater challenges
|
Dec 31, 2025 |
|
2025 in review: In a mess, there is movement—and leadership does matter
|
Dec 24, 2025 |
|
The Directors: Joann Sweasy and Robert Winn reflect on lessons learned during a tough year
|
Dec 19, 2025 |
|
Testing for asbestos in talc-based cosmetics seems like a no-brainer—why did FDA withdraw a rule to standardize it?
|
Dec 17, 2025 |
|
Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
|
Dec 10, 2025 |
|
Roy Herbst remembers the late Edward Chu, “the baritone of reason” and “a gentle giant”
|
Dec 03, 2025 |
|
Oncofertility has been an overlooked standard of care—now states are taking action
|
Nov 26, 2025 |
|
Ellen Sigal and Karen Knudsen “gush” about new CDER Director Richard Pazdur and his late wife, Mary
|
Nov 19, 2025 |
|
Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
|
Nov 12, 2025 |
|
The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery
|
Nov 07, 2025 |
|
Site visits are gone, but outlook for new, centralized CCSG review is bright
|
Nov 05, 2025 |
|
Early endpoints are a balance of risk and benefit
|
Oct 29, 2025 |
|
Cliff Hudis on how AI in cancer care is “inevitable”—and ASCO is working to make it safer
|
Oct 22, 2025 |
|
Latinx oncology leaders talk about the impact of federal policy on cancer outcomes in Latinx communities
|
Oct 15, 2025 |
|
The Directors: Steven Artandi and Eric Winer on how looming policy changes “reverberate” through oncology
|
Oct 10, 2025 |
|
Pulitzer-winning healthcare reporter Laurie McGinley on her shift to advocacy work with PACR
|
Oct 08, 2025 |
|
With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shut down
|
Oct 01, 2025 |
|
Congress seems to have NCI’s back—is cautious optimism warranted? Two former directors say yes.
|
Sep 24, 2025 |
|
Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer
|
Sep 17, 2025 |
|
The Directors: Ben Ho Park and Suresh Ramalingam on tough times, uncertainty, and resilience
|
Sep 12, 2025 |
|
On Capitol Hill, NIH gets congressional support and RFK Jr. gets slammed
|
Sep 10, 2025 |
|
Robert A. Winn on his new vision to train cancer center leaders: “I had a big bold idea and an ‘Aha!’ moment.”
|
Sep 03, 2025 |
|
Gardiner Harris, acclaimed health care and pharma journalist, on his New York Times bestselling book
|
Aug 27, 2025 |
|
In The Headlines: Brian Druker on receiving a record-setting $2B gift to Knight Cancer Institute
|
Aug 20, 2025 |
|
In The Headlines: Late poet Andrea Werblin Reid’s husband talks about publishing her final collection about dying from ovarian cancer
|
Aug 13, 2025 |
|
The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
|
Aug 08, 2025 |
|
In The Headlines: A good week for NIH, a bad week for Vinay Prasad
|
Aug 06, 2025 |
|
In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.
|
Jul 30, 2025 |
|
In the Headlines: Is oncology ready to move away from animal testing?
|
Jul 23, 2025 |
|
The Directors: Mark Evers and Steven Libutti on riding out a tempest—and maintaining research momentum
|
Jul 18, 2025 |
|
In The Headlines: What happens when you apply a tumor board model to financial toxicity?
|
Jul 16, 2025 |
|
In The Headlines: George Weiner on the importance of patients’ stories
|
Jul 09, 2025 |
|
In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”
|
Jul 02, 2025 |
|
In the Headlines: What if curing diseases was treated like a business?
|
Jun 25, 2025 |
|
In the Headlines: Missing record of NCAB meetings restored to NIH website
|
Jun 18, 2025 |
|
The Directors: Candace Johnson and Jonathan Friedberg on getting through the NCI scale-down, payment woes
|
Jun 13, 2025 |
|
In The Headlines: Increasing incidence of early-onset cancer is “a paradigm shift oncology isn’t quite prepared for”
|
Jun 11, 2025 |
|
In The Headlines: Kimryn Rathmell, ASCO, and “an important time in cancer research”
|
Jun 04, 2025 |
|
In The Headlines: Back to “business as usual” at FDA?
|
May 28, 2025 |
|
In The Headlines: Wafik El-Deiry on how “America First” means investing in NCI
|
May 21, 2025 |
|
The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
|
May 16, 2025 |
|
In the Headlines: “There's no one to stand up for NCI right now.”
|
May 14, 2025 |
|
In the Headlines: Centering patients as cancer research infrastructure is dismantled
|
May 07, 2025 |
|
In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?
|
Apr 30, 2025 |
|
In the Headlines: What’s in Trump’s draft budget?
|
Apr 23, 2025 |
|
The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty
|
Apr 18, 2025 |
|
In The Headlines: Oncofertility care falls through the cracks, leaving AYA patients behind
|
Apr 16, 2025 |
|
In The Headlines: Private funding can’t replace federal funding—but it can help
|
Apr 09, 2025 |
|
In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs
|
Apr 02, 2025 |
|
In The Headlines: How tariffs could cause direct harm to patients
|
Mar 26, 2025 |
|
In the Headlines: Could “flooding the zone” drown NIH and cancer centers?
|
Mar 19, 2025 |
|
The Directors: Ray DuBois and Roy Jensen on how COE guides cancer care in rural America
|
Mar 14, 2025 |
|
In the Headlines: What are Jay Bhattacharya’s plans for NIH?
|
Mar 12, 2025 |
|
In The Headlines: When DOGE fires you from your dream job
|
Mar 05, 2025 |
|
In The Headlines: What’s up with the U.S. cancer incidence rate?
|
Feb 26, 2025 |
|
In The Headlines: Kimryn Rathmell on loss and caring for our community in uncertain times
|
Feb 19, 2025 |
|
20 Years of EGFR
|
Feb 14, 2025 |
|
The Directors: Rob Winn and John Carpten on the future of cancer centers
|
Feb 14, 2025 |
|
In The Headlines: Trump moves to cap NIH indirect costs at 15%, HHS agencies webpages removed
|
Feb 14, 2025 |
|
Welcome To The Cancer Letter Podcast
|
Feb 12, 2025 |